Consortium of experts

The Nanovaccine Institute is a consortium of 82 researchers at 25 universities, research institutes, national laboratories, and companies, founded and coordinated by Iowa State University.

Interdisciplinary research

Our research is a transdisciplinary merger of expertise in immunology, nanotechnology, materials science, microbiology, neuroscience, cancer biology, gerontology, clinical science, and social science. We are developing nanovaccines and nanotherapeutics for respiratory infections, neural disorders, antimicrobial resistance, cancer, aging, and animal health. Our vision is that nanovaccines and nanotherapeutics will revolutionize how we prevent and treat disease.